Medical care is entering into a new phase of" personalized" medical care in which diagnosis
and management are tailored to the specific aspects of individual patients. This approach is …

Objective To explore the value of anti-phospholipase A2 receptor (PLA2R) antibody in the
diagnosis and disease activity monitoring of idiopathic membranous nephropathy (IMN) …

The M-type phospholipase A2 receptor (PLA2R) is a target autoantigen in adult idiopathic
membranous nephropathy (MN), but the prevalence of autoantibodies against PLA2R is …

Background. M‐type phospholipase A2 receptor (PLA2R) is the first autoantigen responsible
for idiopathic membranous nephropathy (IMN). However, serum PLA2R antibody (PLA2R …

Background Membranous nephropathy (MN) is the leading cause of nephrotic syndrome in
adults. Anti-M-type phospholipase A2 receptor (anti-PLA2R) antibodies are found in most …

Autoantibodies against the M-type phospholipase A 2 receptor (PLA 2 R) are specific
markers for primary membranous nephropathy (MN). Quantification of PLA 2 R …

Background The diagnostic performance of PLA2R and IgG subclass staining of kidney
biopsies relative to anti-PLA2R seropositivity in the differentiation of primary and secondary …

Background Phospholipase A2 receptor (PLA2R) has been identified as a major
autoantigen in primary membranous nephropathy (MN). We evaluated the association …

Background Circulating serum autoantibodies against the M-type phospholipase A2
receptor (PLA2R-AB) are a key biomarker in the diagnosis and monitoring of primary …

Objectives This study aimed to establish time-resolved fluorescence immunoassays to
quantitatively detect the autoantibodies targeting different epitopes of M-type phospholipase …